From Glorified Post-Doc To Biopharma Cofounder
Source: Life Science Leader
In this executive virtual roundtable (EVR) section, Steffen Mueller, Ph.D., cofounder and CSO, Codagenix, a clinical-stage synthetic-biology company, discusses the impetus to start a biopharmaceutical company, despite his desire to work in academia.
This website uses cookies to ensure you get the best experience on our website. Learn more